Trait centric view

1. Trait name:	Rump width
   Ontology terms:	VT:1000740

   182 genes are associated with this trait, with QTL/association found

   • ACOXL: Acyl-CoA oxidase like
     evidenced by: QTL:45069;
   • ADAMTS16: ADAM metallopeptidase with thrombospondin type 1 motif 16
     evidenced by: QTL:50955;
   • ADAMTS17: ADAM metallopeptidase with thrombospondin type 1 motif 17
     evidenced by: QTL:50964; QTL:50979;
   • ADAMTS6: ADAM metallopeptidase with thrombospondin type 1 motif 6
     evidenced by: QTL:50604;
   • ADAMTSL3: ADAMTS-like 3
     evidenced by: QTL:18768;
   • ADCY3: Adenylate cyclase 3
     evidenced by: QTL:45552; QTL:45566;
   • ALMS1: ALMS1 centrosome and basal body associated protein
     evidenced by: QTL:45133;
   • AMOT: Angiomotin
     evidenced by: QTL:54706;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:42323;
   • ANXA4: Annexin A4
     evidenced by: QTL:45043;
   • AP3B1: Adaptor-related protein complex 3, beta 1 subunit
     evidenced by: QTL:44337;
   • APLF: Aprataxin and PNKP like factor
     evidenced by: QTL:45510;
   • APOA2: Apolipoprotein A-II
     evidenced by: QTL:28099; QTL:28104;
   • ARHGAP10: Rho GTPase activating protein 10
     evidenced by: QTL:48701;
   • ARHGAP6: Rho GTPase activating protein 6
     evidenced by: QTL:55466;
   • BCAS3: BCAS3 microtubule associated cell migration factor
     evidenced by: QTL:50032;
   • BDP1: B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
     evidenced by: QTL:50530;
   • BMP5: Bone morphogenetic protein 5
     evidenced by: QTL:51979;
   • BMPER: BMP binding endothelial regulator
     evidenced by: QTL:64549;
   • BTBD11: BTB domain containing 11
     evidenced by: QTL:41141; QTL:41152; QTL:41159;
   • C3H1ORF87: Chromosome 3 C1orf87 homolog
     evidenced by: QTL:40021;
   • CAPN3: Calpain 3, (p94)
     evidenced by: QTL:44595; QTL:44609;
   • CCDC91: Coiled-coil domain containing 91
     evidenced by: QTL:41337;
   • CD9: CD9 molecule
     evidenced by: QTL:41563;
   • CDH6: Cadherin 6
     evidenced by: QTL:50304;
   • CERS5: Ceramide synthase 5
     evidenced by: QTL:40846;
   • CERS6: Ceramide synthase 6
     evidenced by: QTL:39113;
   • CFAP43: Cilia and flagella associated protein 43
     evidenced by: QTL:52832;
   • CGNL1: Cingulin like 1
     evidenced by: QTL:44773;
   • CHN2: Chimerin 2
     evidenced by: QTL:40458;
   • CHRM3: Cholinergic receptor muscarinic 3
     evidenced by: QTL:53740;
   • CIDEC: Cell death-inducing DFFA-like effector c
     evidenced by: QTL:65383;
   • CLEC16A: C-type lectin domain containing 16A
     evidenced by: QTL:52493;
   • CNTN5: Contactin 5
     evidenced by: QTL:47790;
   • COBLL1: Cordon-bleu WH2 repeat protein like 1
     evidenced by: QTL:39241;
   • COL12A1: Collagen type XII alpha 1 chain
     evidenced by: QTL:51965;
   • COL4A1: Collagen type IV alpha 1 chain
     evidenced by: QTL:46571;
   • CPEB3: Cytoplasmic polyadenylation element binding protein 3
     evidenced by: QTL:52673;
   • CPQ: Carboxypeptidase Q
     evidenced by: QTL:47690;
   • CRTC1: CREB regulated transcription coactivator 1
     evidenced by: QTL:42646;
   • DHX36: DEAH-box helicase 36
     evidenced by: QTL:38704;
   • DOCK1: Dedicator of cytokinesis 1
     evidenced by: QTL:53120;
   • DYSF: Dysferlin
     evidenced by: QTL:45160;
   • EBF1: EBF transcription factor 1
     evidenced by: QTL:43254;
   • EGF: Epidermal growth factor
     evidenced by: QTL:41931;
   • FAS: Fas (TNF receptor superfamily, member 6)
     evidenced by: QTL:52659;
   • FAT3: FAT atypical cadherin 3
     evidenced by: QTL:53879;
   • FBF1: Fas binding factor 1
     evidenced by: QTL:50134;
   • FBLN5: Fibulin 5
     evidenced by: QTL:51399;
   • FER1L5: Fer-1 like family member 5
     evidenced by: QTL:45089;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51697; QTL:51726;
   • GABRR3: Gamma-aminobutyric acid type A receptor rho3 subunit
     evidenced by: QTL:38370;
   • GALNT2: Polypeptide N-acetylgalactosaminyltransferase 2
     evidenced by: QTL:53651;
   • GANC: Glucosidase alpha, neutral C
     evidenced by: QTL:44581;
   • GARS1: Glycyl-tRNA synthetase 1
     evidenced by: QTL:40444;
   • GOLT1A: Golgi transport 1A
     evidenced by: QTL:48060;
   • GPHN: Gephyrin
     evidenced by: QTL:44947;
   • GPM6B: Glycoprotein M6B
     evidenced by: QTL:55447;
   • GRB10: Growth factor receptor-bound protein 10
     evidenced by: QTL:13513;
   • GRB2: Growth factor receptor bound protein 2
     evidenced by: QTL:50145;
   • GRIA3: Glutamate ionotropic receptor AMPA type subunit 3
     evidenced by: QTL:54178; QTL:54195;
   • GRIK2: Glutamate ionotropic receptor kainate type subunit 2
     evidenced by: QTL:44003;
   • GSTO2: Glutathione S-transferase omega 2
     evidenced by: QTL:52848;
   • HGF: Hepatocyte growth factor (hepapoietin A; scatter factor)
     evidenced by: QTL:25222;
   • HSD17B12: Hydroxysteroid (17-beta) dehydrogenase 12
     evidenced by: QTL:47979;
   • HSD17B14: Hydroxysteroid 17-beta dehydrogenase 14
     evidenced by: QTL:49856;
   • IGF2R: Insulin-like growth factor 2 receptor
     evidenced by: QTL:15912; QTL:15917; QTL:15921;
   • ITPK1: Inositol-tetrakisphosphate 1-kinase
     evidenced by: QTL:51431;
   • JAK1: Janus kinase 1
     evidenced by: QTL:39926; QTL:39947;
   • KCNIP1: Potassium voltage-gated channel interacting protein 1
     evidenced by: QTL:50362;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:41974;
   • KCTD2: Potassium channel tetramerization domain containing 2
     evidenced by: QTL:50157;
   • LDLRAD3: Low density lipoprotein receptor class A domain containing 3
     evidenced by: QTL:28135;
   • LETM1: Leucine zipper and EF-hand containing transmembrane protein 1
     evidenced by: QTL:42565;
   • LIPT2: Lipoyl(octanoyl) transferase 2
     evidenced by: QTL:47918;
   • LMO7: LIM domain 7
     evidenced by: QTL:46425;
   • MAGI1: Membrane associated guanylate kinase, WW and PDZ domain containing 1
     evidenced by: QTL:51655;
   • MAPKBP1: Mitogen-activated protein kinase binding protein 1
     evidenced by: QTL:44552;
   • MCUB: Mitochondrial calcium uniporter dominant negative subunit beta
     evidenced by: QTL:41946;
   • MGMT: O-6-methylguanine-DNA methyltransferase
     evidenced by: QTL:53261;
   • MID1: Midline 1
     evidenced by: QTL:55499;
   • MRC2: Mannose receptor C type 2
     evidenced by: QTL:49988;
   • MSGN1: Mesogenin 1
     evidenced by: QTL:45669;
   • MSN: Moesin
     evidenced by: QTL:54829;
   • MSTN: Myostatin
     evidenced by: QTL:31341;
   • MYBPC1: Myosin binding protein C, slow type
     evidenced by: QTL:40993;
   • MYH10: Myosin heavy chain 10
     evidenced by: QTL:215099;
   • MYOG: Myogenin (myogenic factor 4)
     evidenced by: QTL:19952; QTL:19954; QTL:19956;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:38383; QTL:45748; QTL:45763;
   • NCOA1: Nuclear receptor coactivator 1
     evidenced by: QTL:45579;
   • NDP: Norrin cystine knot growth factor NDP
     evidenced by: QTL:54907;
   • NEDD4: Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
     evidenced by: QTL:44794;
   • NELFA: Negative elongation factor complex member A
     evidenced by: QTL:42601;
   • NHS: NHS actin remodeling regulator
     evidenced by: QTL:55246;
   • NPR3: Natriuretic peptide receptor 3
     evidenced by: QTL:50776;
   • NPSR1: Neuropeptide S receptor 1
     evidenced by: QTL:40404;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53795; QTL:53811;
   • NSD2: Nuclear receptor binding SET domain protein 2
     evidenced by: QTL:42585;
   • NT5DC3: 5'-nucleotidase domain containing 3
     evidenced by: QTL:41060;
   • NT5E: 5'-nucleotidase, ecto (CD73)
     evidenced by: QTL:44087;
   • NYAP2: Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2
     evidenced by: QTL:39567;
   • OSBPL10: Oxysterol binding protein like 10
     evidenced by: QTL:51566;
   • OSR1: Odd-skipped related transcription factor 1
     evidenced by: QTL:45632;
   • OTOP3: Otopetrin 3
     evidenced by: QTL:50171;
   • PAH: Phenylalanine hydroxylase
     evidenced by: QTL:41021;
   • PAK5: P21 (RAC1) activated kinase 5
     evidenced by: QTL:46632;
   • PDE4D: Phosphodiesterase 4D
     evidenced by: QTL:50700; QTL:50720;
   • PEG3: Paternally expressed 3
     evidenced by: QTL:13532; QTL:13535;
   • PER2: Period circadian regulator 2
     evidenced by: QTL:40311;
   • PHEX: Phosphate regulating endopeptidase homolog X-linked
     evidenced by: QTL:55158; QTL:55172;
   • PHKA2: Phosphorylase kinase regulatory subunit alpha 2
     evidenced by: QTL:55224; QTL:55234;
   • PITRM1: Pitrilysin metallopeptidase 1
     evidenced by: QTL:47113;
   • PLCD3: Phospholipase C delta 3
     evidenced by: QTL:50060;
   • PLCH1: Phospholipase C eta 1
     evidenced by: QTL:38691;
   • PMP22: Peripheral myelin protein 22
     evidenced by: QTL:49975;
   • PRDM16: PR domain containing 16
     evidenced by: QTL:48326; QTL:48339;
   • PRICKLE1: Prickle planar cell polarity protein 1
     evidenced by: QTL:40885;
   • PRIM2: DNA primase subunit 2
     evidenced by: QTL:51909;
   • PRKD1: Protein kinase D1
     evidenced by: QTL:51189; QTL:51202; QTL:51215;
   • PRLR: Prolactin receptor
     evidenced by: QTL:13128;
   • PRNP: Prion protein
     evidenced by: QTL:1555;
   • PROP1: PROP paired-like homeobox 1
     evidenced by: QTL:25363;
   • PRRX2: Paired related homeobox 2
     evidenced by: QTL:46112;
   • RAB15: RAB15, member RAS oncogene family
     evidenced by: QTL:44932;
   • RAD54B: RAD54 homolog B
     evidenced by: QTL:47718;
   • RARRES2: Retinoic acid receptor responder (tazarotene induced) 2
     evidenced by: QTL:18808; QTL:18809;
   • RASA3: RAS p21 protein activator 3
     evidenced by: QTL:46584;
   • RBMS1: RNA binding motif single stranded interacting protein 1
     evidenced by: QTL:39378;
   • RCAN2: Regulator of calcineurin 2
     evidenced by: QTL:52133;
   • REN: Renin
     evidenced by: QTL:48047;
   • RFX4: Regulatory factor X4
     evidenced by: QTL:41105;
   • RNF157: Ring finger protein 157
     evidenced by: QTL:50093;
   • ROCK2: Rho associated coiled-coil containing protein kinase 2
     evidenced by: QTL:45910; QTL:45924;
   • ROR1: Receptor tyrosine kinase like orphan receptor 1
     evidenced by: QTL:39976;
   • RPAP1: RNA polymerase II associated protein 1
     evidenced by: QTL:44540;
   • RSPO2: R-spondin 2
     evidenced by: QTL:47657;
   • SEC23IP: SEC23 interacting protein
     evidenced by: QTL:53016;
   • SEC24D: SEC24 homolog D, COPII coat complex component
     evidenced by: QTL:41859;
   • SEC63: SEC63 homolog, protein translocation regulator
     evidenced by: QTL:43973;
   • SFXN4: Sideroflexin 4
     evidenced by: QTL:52984;
   • SH2B2: SH2B adaptor protein 2
     evidenced by: QTL:25277; QTL:25278;
   • SH2D2A: SH2 domain containing 2A
     evidenced by: QTL:39752;
   • SHROOM2: Shroom family member 2
     evidenced by: QTL:55649;
   • SIRT1: Sirtuin 1
     evidenced by: QTL:157280; QTL:157281;
   • SLC39A10: Solute carrier family 39 member 10
     evidenced by: QTL:39478;
   • SLC6A1: Solute carrier family 6 member 1
     evidenced by: QTL:51836;
   • SLC6A9: Solute carrier family 6 member 9
     evidenced by: QTL:47029;
   • SLIT3: Slit guidance ligand 3
     evidenced by: QTL:50323; QTL:50342;
   • SMOC1: SPARC related modular calcium binding 1
     evidenced by: QTL:44960;
   • SNX29: Sorting nexin 29
     evidenced by: QTL:52514;
   • SOWAHB: Sosondowah ankyrin repeat domain family member B
     evidenced by: QTL:42366;
   • SPATA3: Spermatogenesis associated 3
     evidenced by: QTL:39612;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:43018; QTL:43034;
   • SPRED2: Sprouty related EVH1 domain containing 2
     evidenced by: QTL:45499;
   • SRGAP2: SLIT-ROBO Rho GTPase activating protein 2
     evidenced by: QTL:48107;
   • SRP68: Signal recognition particle 68
     evidenced by: QTL:50108;
   • SST: Somatostatin
     evidenced by: QTL:18747; QTL:18751; QTL:18754;
   • SYN2: Synapsin II
     evidenced by: QTL:51854;
   • SYN3: Synapsin III
     evidenced by: QTL:41189; QTL:41210;
   • TANK: TRAF family member associated NFKB activator
     evidenced by: QTL:39349;
   • TASP1: Taspase 1
     evidenced by: QTL:46770;
   • TEN1: TEN1 subunit of CST complex
     evidenced by: QTL:50123;
   • TIGAR: TP53 induced glycolysis regulatory phosphatase
     evidenced by: QTL:167542;
   • TIMP2: TIMP metallopeptidase inhibitor 2
     evidenced by: QTL:50078;
   • TLN2: Talin 2
     evidenced by: QTL:44745;
   • TMEM87B: Transmembrane protein 87B
     evidenced by: QTL:45054;
   • TRIM23: Tripartite motif containing 23
     evidenced by: QTL:50589;
   • TRIM68: Tripartite motif containing 68
     evidenced by: QTL:47901;
   • TTYH2: Tweety family member 2
     evidenced by: QTL:50200;
   • UBE2E2: Ubiquitin conjugating enzyme E2 E2
     evidenced by: QTL:53619;
   • UBR1: Ubiquitin protein ligase E3 component n-recognin 1
     evidenced by: QTL:44624; QTL:44638;
   • UNC5D: Unc-5 netrin receptor D
     evidenced by: QTL:53517;
   • WDFY3: WD repeat and FYVE domain containing 3
     evidenced by: QTL:42485;
   • XPO5: Exportin 5
     evidenced by: QTL:52101;
   • XRCC4: X-ray repair cross complementing 4
     evidenced by: QTL:43332;
   • ZBED6: Zinc finger, BED-type containing 6
     evidenced by: QTL:36583; QTL:36593; QTL:36594; QTL:36603; QTL:36604; QTL:36605;
   • ZBTB39: Zinc finger and BTB domain containing 39
     evidenced by: QTL:40973;
   • ZNF215: Zinc finger protein 215
     evidenced by: QTL:13528;
   • ZNF280D: Zinc finger protein 280D
     evidenced by: QTL:44784;
   • ZNF404: Zinc finger protein 404
     evidenced by: QTL:49784;
   • ZNF592: Zinc finger protein 592
     evidenced by: QTL:51143;
   • ZNF746: Zinc finger protein 746
     evidenced by: QTL:40685;
   449 correlations are found involving Rump width